Holen Sie sich die Stockscreener-App
20.49
2.55%
0.51
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
Director adds Zai Lab (ZLAB) ADS under pre-set Rule 10b5-1 plan - Stock Titan
Zai Lab (ZLAB) CEO Du Ying gains ADSs from RSU awards and tax withholding - Stock Titan
ZLABZai Lab Limited ADR Options - Finviz
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - MSN
Zai Lab stock keeps its listing focus. Investors watch the US ADR profile. - ad-hoc-news.de
Zai Lab (ZLAB) CEO sells ADS to cover taxes after RSU vesting - Stock Titan
Form 144 Zai Lab Ltd For: 30 June By Investing.com - Investing.com Nigeria
ZLAB (NASDAQ: ZLAB) insider resale planned on 06/29/2026; recent ADS sales reported - Stock Titan
Zai Lab (ZLAB) legal chief settles RSUs, sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CEO sells ADSs after RSU vesting and tax cover - Stock Titan
CFO equity transactions at Zai Lab (ZLAB) show RSU vesting and tax sale - Stock Titan
Zai Lab ADR outlines oncology pipeline priorities, shares tied to upcoming data - ad-hoc-news.de
ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView
1ZL Forecast — Price Target — Prediction for 2027 - TradingView
Zai Lab Ltd. Sponsored ADR Actuals & Estimates (GETTEX:1ZL) - TradingView
Zai Lab Ltd. Sponsored ADR Actuals & Estimates (LS:A2DX1V) - TradingView
Zai Lab Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:ZLAB) - TradingView
Form 144 Zai Lab Ltd For: 26 June - Investing.com South Africa
Form 144 Zai Lab Ltd For: 26 June By Investing.com - Investing.com Nigeria
ZLAB (NASDAQ) director files to sell 2,264 ADS after vesting - Stock Titan
ZLAB (NASDAQ: ZLAB) director files Form 144 to sell 4,103 ADS on vesting - Stock Titan
ZLAB (NASDAQ: ZLAB) Form 144 shows Ying Du ADS sales and vesting event - Stock Titan
ZLAB/N Forecast — Price Target — Prediction for 2027 - TradingView
Zai Lab (ZLAB) director Lis sells 7,040 ADS under 10b5-1 plan - Stock Titan
Zai Lab (ZLAB) director receives 22,371 ADS restricted share grant - Stock Titan
Director John D. Diekman receives 22,371 Zai Lab (ZLAB) ADS grant - Stock Titan
Zai Lab (ZLAB) director granted 22,371 restricted ADS vesting in 2027 - Stock Titan
Zai Lab (ZLAB) director receives 22,371 ADS stock award, now holds 79,001 ADSs - Stock Titan
Zai Lab (ZLAB) director receives 22,371 ADS restricted stock grant vesting 2027 - Stock Titan
Zai Lab (ZLAB) director receives 22,371 ADS equity award - Stock Titan
Form 144 Zai Lab Ltd For: 22 June By Investing.com - Investing.com Australia
[144] Zai Lab Ltd SEC Filing - Stock Titan
Why Zai Lab (ZLAB) Is Up 6.5% After Dual TIVDAK China Approval and EU Orphan Win – And What's Next - Sahm
Zai Lab Stockanalyst consensus and sector backdrop on a quiet news day - AD HOC NEWS
Zai Lab (NASDAQ: ZLAB) holders back pay and 10% share mandates - Stock Titan
Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas - Business Wire
Number of shareholders of Zai Lab Ltd. Sponsored ADR – SWB:1ZL - TradingView
TCG Crossover funds, Chen Yu hold 5.3% of ZLAB (ADS positions) - Stock Titan
China’s TIVDAK Approval in Advanced Cervical Cancer Could Be A Game Changer For Zai Lab (ZLAB) - Sahm
Assessing Zai Lab (ZLAB) Valuation After China Approval Of TIVDAK For Advanced Cervical Cancer - Sahm
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer - BioSpace
Trial's China arm: TIVDAK cuts death risk 45% vs chemo in cervical cancer - Stock Titan
(tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer - Business Wire
Equity grants for Zai Lab (ZLAB) operating partner Wang Yizhe - Stock Titan
Zai Lab (ZLAB) Operating Partner Wang Yizhe listed as insider on Form 3 - Stock Titan
Zai Lab Ltd (ADR) stock (CA98959U1084): Oncology pipeline and US listing in focus - Ad-hoc-news.de
UnitedHealth, Regeneron Pharmaceuticals and other big stocks moving lower in Monday's pre-market session - MSN
Zai Lab (NASDAQ: ZLAB) CEO gifts 107,700 ADS to adult son’s trusts - Stock Titan
Zai Lab Announces Changes to Senior Leadership Team - Business Wire
Zai Lab Ltd stock (US98887Q1040): analyst downgrade adds pressure after biotech news flow - AD HOC NEWS
Zai Lab Ltd stock (KYG9887Y1016): recent earnings and oncology pipeline in focus - AD HOC NEWS
Zai Lab (ZLAB) CEO sells 100,000 ADS in Rule 10b5-1 trades - Stock Titan
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):